ClassID:

96946

C07K14/503 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Growth factors; Growth regulators; Fibroblast growth factors [FGF] basic FGF [bFGF]

Recent Application in this class:
#1
20260117187
2026-04-30

LIPID NANOPARTICLES FOR BIOPRODUCTION

#2
20260108449
2026-04-23

CAVIAR POLYPEPTIDES

#3
20260049281
2026-02-19

Cell cultivation processes for preparing food products, products provided by said processes and a system for providing these processes

#4
20250361278
2025-11-27

RECOMBINANT PRODUCTION OF GROWTH FACTORS IN ALGAE FOR CELL CULTURE APPLICATIONS

#5
20250333461
2025-10-30

FUSION POLYPEPTIDES FOR METABOLIC DISORDERS

#6
20250257343
2025-08-14

NUCLEIC ACID-BASED THERAPEUTICS

#7
20250257121
2025-08-14

PREPARATION OF TARGET PEPTIDES AND PROTEINS

#8
20250026799
2025-01-23

METHOD FOR PRODUCING CULTURED MEAT

#9
20250019735
2025-01-16

Saccharomyces Cerevisiae Lysate Containing One or More Cytokines, Preparation Method Therefor and Application Thereof in Cell-Cultured Meat

#10
20240277783
2024-08-22

BACTERIUM MODIFIED TO EXPRESS HETEROLOGOUS Tat PROTEIN

#11
20240229058
2024-07-11

PLANT-BASED SYNTHESIS PRODUCTS

#12
20240228566
2024-07-11

COMPOSITIONS AND METHODS FOR VASCULAR PROTECTION AFTER MYOCARDIAL ISCHEMIA

#13
20240182858
2024-06-06

PERICYTE HAVING BASIC FIBROBLAST GROWTH FACTOR (BFGF) GENE INTRODUCED THEREIN

#14
20240132903
2024-04-25

PLANT-BASED SYNTHESIS PRODUCTS

#15
20240116996
2024-04-11

METHODS AND COMPOSITIONS FOR TREATING A CORONAVIRUS INFECTION

#16
20240082405
2024-03-14

Low Molecular Weight Silk Compositions and Stabilizing Silk Compositions

#17
20240034763
2024-02-01

FUSION POLYPEPTIDES FOR METABOLIC DISORDERS

#18
20230151374
2023-05-18

PREPARATION OF HUMAN BASIC FIBROBLAST GROWTH FACTOR BY USING BACILLUS SUBTILIS AND ENDONUCLEASE

#19
20220411757
2022-12-29

Methods for Generating Cardiac Fibroblasts

#20
20220227826
2022-07-21

ENGINEERED FGF1 AND FGF2 COMPOSITIONS AND METHODS OF USE THEREOF

#21
20220056473
2022-02-24

CHIMERIC NUCLEIC ACID MOLECULES WITH NON-AUG TRANSLATION INITIATION SEQUENCES AND USES THEREOF

#22
20220033844
2022-02-03

CHIMERIC NUCLEIC ACID MOLECULES WITH NON-AUG TRANSLATION INITIATION SEQUENCES AND USES THEREOF

#23
20210130786
2021-05-06

Assay for FGF2 Secretion and Signaling

#24
20210024907
2021-01-28

NUCLEIC ACID-BASED THERAPEUTICS

#25
20200270320
2020-08-27

Thermostable FGF2 polypeptide, use thereof

#26
20200188267
2020-06-18

Human fibroblast growth factor-2 mutant with increased stability, and use thereof

#27
20200157164
2020-05-21

Recombinant human-basic fibroblast growth factor (rh-bFGF) and pharmaceutical composition comprising rh-bFGF

#28
20200140509
2020-05-07

Method for producing soluble recombinant human-basic fibroblast growth factor (rh-bFGF)

#29
20200040051
2020-02-06

FIBROBLAST GROWTH FACTOR (FGF) 1 WITH MUTATION IN THE HEPARIN BINDING DOMAIN AND METHODS OF USE TO REDUCE BLOOD GLUCOSE

#30
20190376053
2019-12-12

Collagen-binding agent compositions and methods of using the same

#31
20190284252
2019-09-19

Engineered FGF1 and FGF2 compositions and methods of use thereof

#32
20190233490
2019-08-01

Method of synthesizing antagonist peptides for cell growth

#33
20190218539
2019-07-18

Fusion protein, polynucleotide, genetic construct, producer, preparation for regeneration of cartilage

#34
20190201491
2019-07-04

BOVINE FIBROBLAST GROWTH FACTOR 21 AND KETOSIS IN DAIRY CATTLE

#35
20190127718
2019-05-02

SUPPRESSION OF CANCER

#36
20190015478
2019-01-17

Dominant-negative FGF2 antagonists

#37
20180362606
2018-12-20

Method for preparing composition for promoting hair growth using Nanog-introduced mesenchymal stem cells derived from fetus in amniotic fluid

#38
20180230487
2018-08-16

CHIMERIC NUCLEIC ACID MOLECULES WITH NON-AUG TRANSLATION INITIATION SEQUENCES AND USES THEREOF

#39
20180186850
2018-07-05

Chimeric fibroblast growth factor 19 proteins and methods of use

#40
20180186849
2018-07-05

Chimeric fibroblast growth factor 21 proteins and methods of use

#41
20180163226
2018-06-14

CHIMERIC NUCLEIC ACID MOLECULES WITH NON-AUG TRANSLATION INITIATION SEQUENCES AND USES THEREOF

#42
20180135062
2018-05-17

Recombinant probiotic bacteria

#43
20180127475
2018-05-10

FGF-2 VARIANTS HAVING N-TERMINAL DELETIONS AND INCREASED RECEPTOR SELECTIVITY AND USES THEREOF

#44
20170355740
2017-12-14

METHODS OF USING FIBROBLAST GROWTH FACTOR (FGF) 1 WITH MUTATION IN THE HEPARIN BINDING DOMAIN AND METHODS TO REDUCE BLOOD GLUCOSE

#45
20170319658
2017-11-09

Codon-optimized recombinant plasmid, method of stimulating peripheral nerve regeneration, and method of treating nerve damage in humans

#46
20170291931
2017-10-12

FGF2 TRUNCATIONS AND MUTANTS AND USES THEREOF

#47
20170281790
2017-10-05

Engineered FGF compositions and methods of use thereof

#48
20170143795
2017-05-25

bFGF-polymer conjugates, methods for making the same and applications thereof

#49
20170029480
2017-02-02

Chimeric fibroblast growth factor 21 proteins and methods of use

#50
20170016026
2017-01-19

Chimeric nucleic acid molecules with non-AUG translation initiation sequences and uses thereof

#51
20160376334
2016-12-29

Positive modulator of bone morphogenic protein-2

#52
20160367652
2016-12-22

Chimeric nucleic acid molecules with non-AUG translation initiation sequences and uses thereof

#53
20160354455
2016-12-08

Chimeric nucleic acid molecules with non-AUG translation initiation sequences and uses thereof

#54
20160263228
2016-09-15

Low molecular weight silk compositions and stabilizing silk compositions

#55
20160237133
2016-08-18

CHIMERIC FIBROBLAST GROWTH FACTOR (FGF) 2/FGF1 PEPTIDES AND METHODS OF USE

#56
20160235841
2016-08-18

FGF modulation of in vivo antibody production and humoral immunity

#57
20160206695
2016-07-21

Chimeric fibroblast growth factor (FGF) 2/FGF1 peptides and methods of use

#58
20160137697
2016-05-19

Polynucleotide encoding a fusion protein for improving skin conditions

#59
20160060334
2016-03-03

FGF modulation of in vivo antibody production and humoral immunity

#60
20160060318
2016-03-03

Means and method for expression of authentic human epidermal growth factor and/or basic fibrolast growth factor in cytoplasm and/or culture medium of

#61
20160046679
2016-02-18

LOW MOLECULAR WEIGHT SILK COMPOSITIONS AND STABILIZING SILK COMPOSITIONS

#62
20150353615
2015-12-10

Positive modulator of bone morphogenic protein-2

#63
20150322126
2015-11-12

FGF-2 variants having N-terminal deletions and increased receptor selectivity and methods of use thereof

#64
20150290259
2015-10-15

Therapeutic agent for ischemic diseases

#65
20150284443
2015-10-08

Fibroblast growth factor muteins with increased activity

#66
20150141627
2015-05-21

Method for antigen delivery

#67
20150072426
2015-03-12

FGF-2 variants and methods of use thereof

#68
20150044166
2015-02-12

COMPOSITIONS AND METHODS FOR TREATMENT OF EXERCISE-INDUCED PULMONARY HEMORRHAGE OR NASOPHARYNGEAL CICATRIX

#69
20140316109
2014-10-23

Activated collagen scaffold materials and their special fused active restoration factors

#70
20140315253
2014-10-23

Activated collagen scaffold materials and their special fused active restoration factors

#71
20140286925
2014-09-25

Suppression of cancer

#72
20130338070
2013-12-19

FGF-9 variants and methods of use thereof

#73
20130331317
2013-12-12

Chimeric fibroblast growth factor 19 proteins and methods of use

#74
20130331316
2013-12-12

Chimeric fibroblast growth factor 21 proteins and methods of use

#75
20130236483
2013-09-12

FGF modulation of in vivo antibody production and humoral immunity

#76
20130236474
2013-09-12

FGF modulation of in vivo antibody production and humoral immunity

#77
20130011367
2013-01-10

Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis

#78
20120316113
2012-12-13

FGF BASED FIBRIN BINDING PEPTIDES

#79
20120309694
2012-12-06

Dual Chain Synthetic Heparin-Binding Growth Factor Analogs

#80
20120308544
2012-12-06

Substances and Methods for the Treatment of Lysosmal Storage Diseases

#81
20120225479
2012-09-06

Thermostable variants of fibroblast growth factors

#82
20120214740
2012-08-23

Medicinal Compositions Containing Highly Functionalized Chimeric Protein

#83
20120214739
2012-08-23

FGF-9 variants and methods for use thereof

#84
20120122156
2012-05-17

RECOMBINANT PROTEIN OF FIBROBLAST GROWTH FACTOR HAVING ADHESIVE ACTIVITY FOR STEM CELLS AND METHOD FOR CULTURING STEM CELLS USING THE SAME

#85
20120065129
2012-03-15

METHOD OF MASS PRODUCING GROWTH FACTOR USING ADIPOSE DERIVED ADULT STEM CELLS

#86
20110269231
2011-11-03

PROTEOGLYCAN-BINDING PEPTIDES THAT MODULATE STEM CELL BEHAVIOR

#87
20110262423
2011-10-27

SUPPRESSION OF CANCER

#88
20110207985
2011-08-25

PROMOTERS EXHIBITING ENDOTHELIAL CELL SPECIFICITY AND METHODS OF USING SAME FOR REGULATION OF ANGIOGENESIS

#89
20110207663
2011-08-25

Fibroblast growth factor (FGF) analogs and uses thereof

#90
20110129511
2011-06-02

Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis

#91
20110081359
2011-04-07

Alpha 5 beta 1 and its ability to regulate the cell survival pathway

#92
20110053841
2011-03-03

FGF-2 variants having N-terminal deletions and increased receptor selectivity and uses thereof

#93
20100323962
2010-12-23

Method of reduction of wrinkles on skin or acceleration of wound healing by applying peptides related to basic fibroblast growth factor (bFGF)

#94
20100286042
2010-11-11

Medicinal Composition Containing Highly Functionalized Chimeric Protein

#95
20100267650
2010-10-21

Dual chain synthetic heparin-binding growth factor analogs

#96
20100210568
2010-08-19

THYROTROPIN RELEASING HORMONE FOR THERAPEUTIC APPLICATIONS

#97
20100210561
2010-08-19

USE OF PEPTIDE AS A THERAPEUTIC AGENT

#98
20100204153
2010-08-12

USE OF BAND 3 PROTEIN (824-829) AND/OR MELANOCYTE-STIMULATING HORMONE RELEASE-INHIBITING FACTOR AS A THERAPEUTIC AGENT IN THE TREATMENT OF PSEUDOMONAS AERUGINOSA INFECTION

#99
20100144632
2010-06-10

Truncated 24kDa basic fibroblast growth factor

#100
20100081193
2010-04-01

Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis

#101
20090305352
2009-12-10

Activated collagen scaffold materials and their special fused active restoration factors

#102
20090247462
2009-10-01

FGF variants and methods for use thereof

#103
20090124556
2009-05-14

Method for improving skin conditions

#104
20090074769
2009-03-19

GLP-1 analog fusion proteins

#105
20090069233
2009-03-12

Agonist Peptides of Basic Fibroblast Growth Factor (bFGF) and the Method of Reduction of Wrinkles on Skin, Darkening of Hair and Acceleration of Wound Healing

#106
20090004160
2009-01-01

Mass producing growth factor using adipose derived adult stem cells

#107
20080166392
2008-07-10

Positive Modulator of Bone Morphogenic Protein-2

#108
20080152689
2008-06-26

DEVICES CONTAINING DNA ENCODING NEUROTROPHIC AGENTS AND RELATED COMPOSITIONS AND METHODS

#109
20080051356
2008-02-28

Truncated 24kDa basic fibroblast growth factor

#110
20070253966
2007-11-01

Fusion Proteins

#111
20070036806
2007-02-15

GLP-1 analog fusion proteins

#112
20070027080
2007-02-01

Method for treatment of vitiligo

#113
20060035825
2006-02-16

Alpha 5 beta 1 and its ability to regulate the cell survival pathway

#114
20060014693
2006-01-19

Peptide inhibiting platelet derived growth factor (PDGF-BB) and fibroblast growth factor (bFGF) activity

#115
20050227329
2005-10-13

Recombinant fibroblast growth factor analogs

#116
20050222394
2005-10-06

Dual chain synthetic heparin-binding growth factor analogs

#117
20050196425
2005-09-08

Positive modulator of bone morphogenic protein-2

#118
20050187150
2005-08-25

Structure-based design and synthesis of FGF inhibitors and FGF modulator compounds

#119
20050186179
2005-08-25

Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis

#120
20050159350
2005-07-21

Methods of using analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamate 89, asparate 101 or leucine 137

#121
20050148511
2005-07-07

FGF variants and methods for use thereof

#122
20050143294
2005-06-30

Analogs of cationic proteins

#123
20050080241
2005-04-14

Polynucleotide, vector, host cell and method for producing human hepatoma-derived growth factor 5 polypeptide